Research Topics
| Carlene M M LawesSummaryAffiliation: University of Auckland Country: New Zealand Publications
| Collaborators
|
Detail Information
Publications
Statin use in COPD patients is associated with a reduction in mortality: a national cohort studyCarlene M M Lawes
Clinical Trials Research Unit, University of Auckland, Auckland, New Zealand
Prim Care Respir J 21:35-40. 2012..To assess whether statin use is associated with reduced mortality in patients with chronic obstructive pulmonary disease (COPD)...
Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burdenCarlene M M Lawes
Clinical Trials Research Unit, University of Auckland, Auckland, New Zealand
J Hypertens 24:423-30. 2006..To provide estimates of the global burden of disease attributable to non-optimal blood pressure by age and sex for adults aged > or = 30 years, by WHO subregion...
Blood pressure and the global burden of disease 2000. Part 1: estimates of blood pressure levelsCarlene M M Lawes
Clinical Trials Research Unit, University of Auckland, Auckland, New Zealand
J Hypertens 24:413-22. 2006..To provide global estimates of blood pressure by age and sex for adults aged > or = 30 years, by WHO subregion...
Blood pressure indices and cardiovascular disease in the Asia Pacific region: a pooled analysisCarlene M M Lawes
Clinical Trials Research Unit, University of Auckland, Private Bag 92019, Auckland, New Zealand
Hypertension 42:69-75. 2003..These data suggest that if time or resources are highly constrained, such as in much-needed epidemiologic surveys in developing countries, very little is lost from only measuring SBP...
Blood pressure and stroke: an overview of published reviewsCarlene M M Lawes
Clinical Trials Research Unit, Department of Medicine, University of Auckland, Auckland, New Zealand
Stroke 35:776-85. 2004..This article provides an overview of published reviews of the effects on stroke seen in trials of BP-lowering drugs and compares these with the results available from cohort studies...
Blood pressure and stroke: an overview of published reviewsCarlene M M Lawes
Clinical Trials Research Unit, Department of Medicine, University of Auckland, Auckland, New Zealand
Stroke 35:1024. 2004..This article provides an overview of published reviews of the effects on stroke seen in trials of BP-lowering drugs and compares these with the results available from cohort studies...
Blood pressure and coronary heart disease: a review of the evidenceCarlene M M Lawes
Clinical Trials Research Unit, Department of Medicine, University of Auckland, New Zealand
Semin Vasc Med 2:355-68. 2002..Finally, and most importantly, the large majority of people have suboptimal blood pressure (e.g., systolic > 115 mm Hg) and so initiatives to lower blood pressure population-wide are an essential adjunct to targeted treatment programs...
Smoking and elevated blood pressure are the most important risk factors for subarachnoid hemorrhage in the Asia-Pacific region: an overview of 26 cohorts involving 306,620 participantsValery Feigin
Department of Medicine and School of Population Health, Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand
Stroke 36:1360-5. 2005....
Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studiesValery L Feigin
Clinical Trials Research Unit, Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand
Stroke 36:2773-80. 2005..After a 1996 review from our group on risk factors for subarachnoid hemorrhage (SAH), much new information has become available. This article provides an updated overview of risk factors for SAH...
Attention deficits after incident stroke in the acute period: frequency across types of attention and relationships to patient characteristics and functional outcomesSuzanne L Barker-Collo
Department of Psychology, University of Auckland, Auckland, New Zealand
Top Stroke Rehabil 17:463-76. 2010..Attention deficits are common post stroke and result in poorer functional outcomes. This study examined the frequency of attention deficits after incident stroke and their correlates...
Neuropsychological profiles of 5-year ischemic stroke survivors by Oxfordshire stroke classification and hemisphere of lesionSuzanne Barker-Collo
Department of Psychology, The University of Auckland, Private Bag 92019, Auckland, New Zealand
Stroke 43:50-5. 2012..This article examined profiles of cognitive function by hemisphere and by Oxfordshire Community Stroke Project stroke classification...
Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular riskRod Jackson
Section of Epidemiology and Biostatistics, School of Population Health, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
Lancet 365:434-41. 2005..An affordable daily pill combining low doses of various drugs could be useful for the many individuals with slightly abnormal cardiovascular risk factors...
Global burden of blood-pressure-related disease, 2001Carlene M M Lawes
Clinical Trials Research Unit, University of Auckland, Auckland, New Zealand
Lancet 371:1513-8. 2008..Few studies have assessed the extent and distribution of the blood-pressure burden worldwide. The aim of this study was to quantify the global burden of disease related to high blood pressure...
Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th centuryValery L Feigin
Department of Medicine, Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand
Lancet Neurol 2:43-53. 2003....
Mortality attributable to higher-than-optimal body mass index in New ZealandCliona Ni Mhurchu
Public Health Intelligence Unit, Ministry of Health, Wellington, New Zealand
Public Health Nutr 8:402-8. 2005..To estimate the burden of mortality in New Zealand due to higher-than-optimal body mass index (BMI) in 1997, as well as mortality that could be avoided in 2011 with feasible changes in mean population BMI...
Reducing attention deficits after stroke using attention process training: a randomized controlled trialSuzanne L Barker-Collo
Clinical Training Programme, Department of Psychology Tamaki Campus, Faculty of Science, University of Auckland, Auckland, New Zealand
Stroke 40:3293-8. 2009..There was no evidence for effectiveness of APT in stroke patients. This trial evaluated effectiveness of APT in improving attention and broader outcomes in stroke survivors 6 months after stroke...
The Perindopril Protection Against Recurrent Stroke Study (PROGRESS): clinical implications for older patients with cerebrovascular diseaseYogini Ratnasabapathy
Clinical Trials Research Unit, University of Auckland, Auckland, New Zealand
Drugs Aging 20:241-51. 2003....
Estimating energy expenditure with the RT3 triaxial accelerometerRalph Maddison
Clinical Trials Research Unit, University of Auckland, New Zealand
Res Q Exerc Sport 80:249-56. 2009..The RT3 provided a relatively accurate assessment of free-living activity-related energy expenditure at the group level and generally underestimated total and activity-related energy expenditure compared to DLW..
No effect of ultraviolet radiation on blood pressure and other cardiovascular risk factorsRobert Scragg
Epidemiology and Biostatistics, School of Population Health, University of Auckland, Auckland, New Zealand
J Hypertens 29:1749-56. 2011..The study aim is to determine if exposure to ultraviolet B radiation, which synthesizes vitamin D, lowers blood pressure, compared with ultraviolet A radiation...
Ethnic disparity of pancreatic cancer in New ZealandAnthony R J Phillips
Department of Surgery, Faculty of Medical and Health Science, University of Auckland, Auckland, New Zealand
Int J Gastrointest Cancer 31:137-45. 2002..The etiology of pancreatic cancer remains elusive. Identification of high-risk groups may enable targeted study to identify new markers and risk factors...
Rethinking the "diseases of affluence" paradigm: global patterns of nutritional risks in relation to economic developmentMajid Ezzati
Harvard School of Public Health, Boston, Massachusetts, USA
PLoS Med 2:e133. 2005....
Cigarette smoking, systolic blood pressure, and cardiovascular diseases in the Asia-Pacific regionKoshi Nakamura
Nutrition and Lifestyle Division, The George Institute for International Health, PO Box M201, Missenden Road, Camperdown, NSW 2050, Australia
Stroke 39:1694-702. 2008..If these 2 risk factors have a synergistic impact on cardiovascular events, lowering BP and quitting smoking will contribute more to reducing CVD than would be expected from ignoring their interaction...
Hypertension: its prevalence and population-attributable fraction for mortality from cardiovascular disease in the Asia-Pacific regionAlexandra L C Martiniuk
The George Institute for International Health at the University of Sydney, Australia
J Hypertens 25:73-9. 2007....
Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessmentGoodarz Danaei
Harvard School of Public Health, Boston, MA 02115, USA
Lancet 368:1651-9. 2006..Programmes for cardiovascular risk and diabetes management and control at the population level need to be more closely integrated...
Cardiovascular mortality attributable to high blood cholesterol in New ZealandMaria L Turley
Public Health Intelligence, Ministry of Health, Wellington, New Zealand
Aust N Z J Public Health 30:252-7. 2006....
Nutrition and the burden of disease in New Zealand: 1997-2011Niki Stefanogiannis
Public Health Intelligence, Ministry of Health, PO Box 5013, Wellington, New Zealand
Public Health Nutr 8:395-401. 2005..Small changes in the population distribution of these risk factors could have a major impact on population health within a decade...
Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease riskChristopher J L Murray
Evidence and Information for Policy, World Health Organization, 27, Geneva, Switzerland
Lancet 361:717-25. 2003..INTERPRETATION: The combination of personal and non-personal health interventions evaluated here could lower the global incidence of cardiovascular events by as much as 50%...
